Skip to main content

Analysis

Intermountain Healthcare CEO Marc Harrison Undergoing Cancer Treatment

By John Commins  
   November 05, 2019

Harrison will remain CEO of the Salt Lake City-based health system while undergoing treatment.

Intermountain Healthcare President and CEO Marc Harrison, MD, announced this week that he will undergo treatment for multiple myeloma.

"Cancer is never good news, of course, but I have every reason to hope for a successful outcome," Harrison said in a media release.

"I am proud and grateful that my care will be provided by Intermountain caregivers – the best in the land. I look forward to their care and support as I continue to serve our communities as CEO of Intermountain," he said.

Harrison is expected to return to the C Suite in early 2020, and will remain CEO of the Salt Lake City-based health system while undergoing treatment, Intermountain said.

"While multiple myeloma is not yet fixable, it can be managed effectively with a range of medical therapies, and today can be treated as a chronic disease," Harrison said. "Many people live successfully with chronic diseases such as diabetes, high blood pressure, and asthma. This is my chronic disease."

Harrison has been president and CEO of Intermountain since October 2016. The not-for-profit health system has operations in Utah, Idaho and Nevada, and includes 24 hospitals, 215 clinics, a Medical Group with 2,500 employed physicians, and SelectHealth insurance company.  

“I am proud and grateful that my care will be provided by Intermountain caregivers – the best in the land.”

John Commins is a content specialist and online news editor for HealthLeaders, a Simplify Compliance brand.


KEY TAKEAWAYS

Harrison is expected to return to the C Suite in early 2020.

Harrison has been president and CEO of Intermountain since October 2016.


Get the latest on healthcare leadership in your inbox.